Clinical and cortical decline in the aphasic variant of Alzheimer's disease

Emily Rogalski, Jaiashre Sridhar, Adam Martersteck, Benjamin Rader, Derin Cobia, Anupa K. Arora, Angela J. Fought, Eileen H Bigio, Sandra Weintraub, Marek-Marsel Mesulam, Alfred W Rademaker

Research output: Contribution to journalArticle

Abstract

Introduction: Primary progressive aphasia (PPA) displays variable progression trajectories that require further elucidation. Methods: Longitudinal quantitation of atrophy and language over 12 months was completed for PPA patients with and without positive amyloid PET (PPA Aβ+ and PPA Aβ− ), an imaging biomarker of underlying Alzheimer's disease. Results: Over 12 months, both PPA groups showed significantly greater cortical atrophy rates in the left versus right hemisphere, with a more widespread pattern in PPA Aβ+ . The PPA Aβ+ group also showed greater decline in performance on most language tasks. There was no obligatory relationship between the logopenic PPA variant and amyloid status. Effect sizes from quantitative MRI data were more robust than neuropsychological metrics. Discussion: Preferential language network neurodegeneration is present in PPA irrespective of amyloid status. Clinical and anatomical progression appears to differ for PPA due to Alzheimer's disease versus non–Alzheimer's disease neuropathology, a distinction that may help to inform prognosis and the design of intervention trials.

Original languageEnglish (US)
Pages (from-to)543-552
Number of pages10
JournalAlzheimer's and Dementia
Volume15
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Primary Progressive Aphasia
Alzheimer Disease
Language
Amyloid
Atrophy

Keywords

  • Amyloid PET
  • Biomarker
  • FreeSurfer
  • Frontotemporal dementia
  • Frontotemporal lobar degeneration
  • Neuropsychology
  • Primary progressive aphasia
  • Progression
  • Volumetric MRI

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Cite this

Rogalski, Emily ; Sridhar, Jaiashre ; Martersteck, Adam ; Rader, Benjamin ; Cobia, Derin ; Arora, Anupa K. ; Fought, Angela J. ; Bigio, Eileen H ; Weintraub, Sandra ; Mesulam, Marek-Marsel ; Rademaker, Alfred W. / Clinical and cortical decline in the aphasic variant of Alzheimer's disease. In: Alzheimer's and Dementia. 2019 ; Vol. 15, No. 4. pp. 543-552.
@article{d97720defec940ebaf957e43f18974ba,
title = "Clinical and cortical decline in the aphasic variant of Alzheimer's disease",
abstract = "Introduction: Primary progressive aphasia (PPA) displays variable progression trajectories that require further elucidation. Methods: Longitudinal quantitation of atrophy and language over 12 months was completed for PPA patients with and without positive amyloid PET (PPA Aβ+ and PPA Aβ− ), an imaging biomarker of underlying Alzheimer's disease. Results: Over 12 months, both PPA groups showed significantly greater cortical atrophy rates in the left versus right hemisphere, with a more widespread pattern in PPA Aβ+ . The PPA Aβ+ group also showed greater decline in performance on most language tasks. There was no obligatory relationship between the logopenic PPA variant and amyloid status. Effect sizes from quantitative MRI data were more robust than neuropsychological metrics. Discussion: Preferential language network neurodegeneration is present in PPA irrespective of amyloid status. Clinical and anatomical progression appears to differ for PPA due to Alzheimer's disease versus non–Alzheimer's disease neuropathology, a distinction that may help to inform prognosis and the design of intervention trials.",
keywords = "Amyloid PET, Biomarker, FreeSurfer, Frontotemporal dementia, Frontotemporal lobar degeneration, Neuropsychology, Primary progressive aphasia, Progression, Volumetric MRI",
author = "Emily Rogalski and Jaiashre Sridhar and Adam Martersteck and Benjamin Rader and Derin Cobia and Arora, {Anupa K.} and Fought, {Angela J.} and Bigio, {Eileen H} and Sandra Weintraub and Marek-Marsel Mesulam and Rademaker, {Alfred W}",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.jalz.2018.12.003",
language = "English (US)",
volume = "15",
pages = "543--552",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",
number = "4",

}

Clinical and cortical decline in the aphasic variant of Alzheimer's disease. / Rogalski, Emily; Sridhar, Jaiashre; Martersteck, Adam; Rader, Benjamin; Cobia, Derin; Arora, Anupa K.; Fought, Angela J.; Bigio, Eileen H; Weintraub, Sandra; Mesulam, Marek-Marsel; Rademaker, Alfred W.

In: Alzheimer's and Dementia, Vol. 15, No. 4, 01.04.2019, p. 543-552.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical and cortical decline in the aphasic variant of Alzheimer's disease

AU - Rogalski, Emily

AU - Sridhar, Jaiashre

AU - Martersteck, Adam

AU - Rader, Benjamin

AU - Cobia, Derin

AU - Arora, Anupa K.

AU - Fought, Angela J.

AU - Bigio, Eileen H

AU - Weintraub, Sandra

AU - Mesulam, Marek-Marsel

AU - Rademaker, Alfred W

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Introduction: Primary progressive aphasia (PPA) displays variable progression trajectories that require further elucidation. Methods: Longitudinal quantitation of atrophy and language over 12 months was completed for PPA patients with and without positive amyloid PET (PPA Aβ+ and PPA Aβ− ), an imaging biomarker of underlying Alzheimer's disease. Results: Over 12 months, both PPA groups showed significantly greater cortical atrophy rates in the left versus right hemisphere, with a more widespread pattern in PPA Aβ+ . The PPA Aβ+ group also showed greater decline in performance on most language tasks. There was no obligatory relationship between the logopenic PPA variant and amyloid status. Effect sizes from quantitative MRI data were more robust than neuropsychological metrics. Discussion: Preferential language network neurodegeneration is present in PPA irrespective of amyloid status. Clinical and anatomical progression appears to differ for PPA due to Alzheimer's disease versus non–Alzheimer's disease neuropathology, a distinction that may help to inform prognosis and the design of intervention trials.

AB - Introduction: Primary progressive aphasia (PPA) displays variable progression trajectories that require further elucidation. Methods: Longitudinal quantitation of atrophy and language over 12 months was completed for PPA patients with and without positive amyloid PET (PPA Aβ+ and PPA Aβ− ), an imaging biomarker of underlying Alzheimer's disease. Results: Over 12 months, both PPA groups showed significantly greater cortical atrophy rates in the left versus right hemisphere, with a more widespread pattern in PPA Aβ+ . The PPA Aβ+ group also showed greater decline in performance on most language tasks. There was no obligatory relationship between the logopenic PPA variant and amyloid status. Effect sizes from quantitative MRI data were more robust than neuropsychological metrics. Discussion: Preferential language network neurodegeneration is present in PPA irrespective of amyloid status. Clinical and anatomical progression appears to differ for PPA due to Alzheimer's disease versus non–Alzheimer's disease neuropathology, a distinction that may help to inform prognosis and the design of intervention trials.

KW - Amyloid PET

KW - Biomarker

KW - FreeSurfer

KW - Frontotemporal dementia

KW - Frontotemporal lobar degeneration

KW - Neuropsychology

KW - Primary progressive aphasia

KW - Progression

KW - Volumetric MRI

UR - http://www.scopus.com/inward/record.url?scp=85061268956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061268956&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2018.12.003

DO - 10.1016/j.jalz.2018.12.003

M3 - Article

VL - 15

SP - 543

EP - 552

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

IS - 4

ER -